Profile for ambanonveegepo
- User Type: User
-
Rank:
New Member
- Register Date: 10 Aoû 2019
- Last login: 6 years 7 months ago
- Time Zone: UTC +1:00
- Local Time: 06:47
- Profile views: 1
- Location: Philadelphia
31 Jan 2019 Mylan Announces FDA Approval of Wixela™ Inhub™ (fluticasone USP), First Generic of ADVAIR DISKUS® (fluticasone propionate 500 mcg/50 mcg strengths for asthma patients and the 250 mcg/50 mcg strength for COPD patients. beta agonists; maintenance treatment of COPD; and the...